In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis.
Supriya KhanraSubir Kumar JuinJunaid Jibran JawedSweta GhoshShreyasi DuttaShaik Abdul NabiJyotirmayee DashDipak DasguptaSubrata MajumdarRahul BanerjeePublished in: PLoS neglected tropical diseases (2020)
All experiments affirmed the efficacy of suramin against L. donovani infection, which could possibly lead to its inclusion in the repertoire of drugs against VL.